Financhill
Back

Akebia Therapeutics Vs. Theriva Biologics Industry Stock Comparison

Buy
66

AKBA
Akebia Therapeutics

Last Price:
2.05
Seasonality Move:
28.83%
Sell
38

TOVX
Theriva Biologics

Last Price:
1.33
Seasonality Move:
10.97%
Buy
66
Akebia Therapeutics (AKBA) is a Buy

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $2.04. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy, Sell or Hold?

  • The current Theriva Biologics [TOVX] share price is $1.30. The Score for TOVX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • TOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $2.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing selling pressure, which indicates risk of future bearish movement.

TOVX Stock Price Chart

What is Theriva Biologics's stock price today?

  • The Theriva Biologics share price today is $1.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 64.07 Buy
Chaikin Money Flow: -2084803 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.76 - 2.02) Buy
Bollinger Bands (100): (1.26 - 1.76) Buy

TOVX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 39.87 Sell
Chaikin Money Flow: -78871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.23 - 1.83) Sell
Bollinger Bands (100): (1.31 - 5.19) Sell

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2 Buy
20-day SMA: 1.93 Buy
50-day SMA: 1.63 Buy
200-day SMA: 1.43 Buy
8-day EMA: 2.01 Buy
20-day EMA: 1.91 Buy
50-day EMA: 1.72 Buy
200-day EMA: 1.45 Buy

TOVX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.33 Sell
20-day SMA: 1.49 Sell
50-day SMA: 1.58 Sell
200-day SMA: 6.32 Sell
8-day EMA: 1.35 Sell
20-day EMA: 1.44 Sell
50-day EMA: 1.95 Sell
200-day EMA: 5.83 Sell

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.

Theriva Biologics Earnings Growth & TOVX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):